$3.59
0.041.13%
At Close: -
$3.50
-0.09-2.51%
After Hours: 4:17 PM EDT
15 minutes delayed
Macrogenics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Macrogenics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.89 | $-0.59 | -50.8 % |
Mar 2024 | 2024-05-09 | $-0.84 | $-0.64 | -31.3 % |
Dec 2023 | 2024-03-07 | $-0.75 | $-0.15 | -400.0 % |
Sep 2023 | 2023-11-06 | $0.28 | $-0.10 | 380.0 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $10.80M | $21.24M | -49.2 % |
Mar 2024 | 2024-05-09 | $9.10M | $14.62M | -37.7 % |
Sep 2023 | 2023-11-06 | $10.40M | $48.86M | -78.7 % |
Jun 2023 | 2023-08-09 | $13.14M | $29.74M | -55.8 % |
Macrogenics (MGNX) is scheduled to report earnings on November 4, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.89, which missed the estimate of $-0.59.
The Actual Revenue was $10.8M, which missed the estimate of $21.2M.
Browse earnings estimates, EPS, and revenue on all stocks.